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The cilium, a protrusion from the cell surface, has recently
attracted immense attention due to its importance in cell
signaling and its association with a wide range of human
disorders. On the structural level, the cilium consists of a
ring of nine microtubule doublets along which the bidirec-
tional movement of ciliary building blocks and turnover
products takes place. This transport is termed intraflagel-
lar transport (IFT) and is carried out by two distinct
multi-subunit protein complexes, IFT complex A and B,
which are responsible for retrograde and anterograde
transport, respectively. IFT complex B consists of at least
14 different proteins, eight of which are known to form a
salt-stable core complex. Our research focuses on the IFT
complex B core. The eight IFT genes from Trypanosoma
brucei have been cloned into 4 Duet vectors (Novagen) to
enable a simultaneous co-expression of the core complex.
Upon co-expression in E. coli, the complex has been puri-
fied with minor impurities using Zinc-NTA affinity and
size-exclusion chromatography. Six of the eight proteins
have been confirmed via mass spectrometry and Western
blot. On size-exclusion chromatography, different oligo-
meric states of the complex can be observed, ranging from
>8MDa to around 600 kDa. Preliminary data suggests
a liposome-binding capability of the complex, but the
responsible subunit(s) remains to be elucidated. Since
crystallization of the purified complex has not been suc-
cessful, future studies will focus on electron microscopy
analysis of the recombinant IFT complex B core.
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